RQ-00310941

N/A

Report date: 2024/04/19 14:36:29
NME

Base Information

Drug NameRQ-00310941
Drug Alias Name5-HT2B Antagonist (RaQualia)RQ-00310941
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptor
Therapy Area/IndicationsIrritable Bowel SyndromeInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Japan Inc
China Registration ClassN/A

Develop Information

Active CompaniesRaqualia Pharma Inc
Inactive CompaniesN/A
Active IndicationsIrritable Bowel SyndromeInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A